Combined epigenetic and genetic biomarkers in chemoradiotherapy of cervical cancer
- Prosjektnummer
- 2012015
- Ansvarlig person
- Heidi Lyng
- Institusjon
- Oslo universitetssykehus HF
- Prosjektkategori
- Postdoktorstipend
- Helsekategori
- Cancer
- Forskningsaktivitet
- 4. Detection and Diagnosis
Hypoxia-induced alterations of G2 checkpoint regulators.
Mol Oncol 2016 May;10(5):764-73. Epub 2016 jan 8
PMID: 26791779
Integrative Analysis of DCE-MRI and Gene Expression Profiles in Construction of a Gene Classifier for Assessment of Hypoxia-Related Risk of Chemoradiotherapy Failure in Cervical Cancer.
Clin Cancer Res 2016 Aug 15;22(16):4067-76. Epub 2016 mar 24
PMID: 27012812
Aberrant methylation-mediated silencing of microRNAs contributes to HPV-induced anchorage independence.
Oncotarget 2016 Jul 12;7(28):43805-43819.
PMID: 27270309
Interplay between promoter methylation and chromosomal loss in gene silencing at 3p11-p14 in cervical cancer.
Epigenetics 2015;10(10):970-80.
PMID: 26291246
Identification of eight candidate target genes of the recurrent 3p12-p14 loss in cervical cancer by integrative genomic profiling.
J Pathol 2013 May;230(1):59-69. Epub 2013 mar 14
PMID: 23335387
Gene network reconstruction reveals cell cycle and antiviral genes as major drivers of cervical cancer.
Nat Commun 2013;4():1806.
PMID: 23651994
Hypoxia-induced gene expression in chemoradioresistant cervical cancer revealed by dynamic contrast-enhanced MRI.
Cancer Res 2012 Oct;72(20):5285-95. Epub 2012 aug 13
PMID: 22890239
- Heidi Lyng Prosjektleder
- Malin Lando Prosjektdeltaker
eRapport er utarbeidet av Sølvi Lerfald og Reidar Thorstensen, Regionalt kompetansesenter for klinisk forskning, Helse Vest RHF, og videreutvikles av de fire RHF-ene i fellesskap, med støtte fra Helse Vest IKT
Alle henvendelser rettes til eRapport